nodes	percent_of_prediction	percent_of_DWPC	metapath
Rivaroxaban—CYP3A4—Temozolomide—brain cancer	0.183	0.342	CbGbCtD
Rivaroxaban—CYP3A4—Lomustine—brain cancer	0.156	0.291	CbGbCtD
Rivaroxaban—CYP3A5—Etoposide—brain cancer	0.0965	0.18	CbGbCtD
Rivaroxaban—ABCB1—Etoposide—brain cancer	0.0628	0.117	CbGbCtD
Rivaroxaban—CYP3A4—Etoposide—brain cancer	0.0376	0.0702	CbGbCtD
Rivaroxaban—CYP2J2—Arachidonate Epoxygenase / Epoxide Hydrolase—CYP2C9—brain cancer	0.0305	0.213	CbGpPWpGaD
Rivaroxaban—CYP2J2—Synthesis of epoxy (EET) and dihydroxyeicosatrienoic acids (DHET)—CYP2C9—brain cancer	0.0274	0.192	CbGpPWpGaD
Rivaroxaban—CYP2J2—Xenobiotics—CYP2C9—brain cancer	0.0132	0.0921	CbGpPWpGaD
Rivaroxaban—Hemiparesis—Temozolomide—brain cancer	0.0119	0.0404	CcSEcCtD
Rivaroxaban—Contusion—Lomustine—brain cancer	0.00746	0.0253	CcSEcCtD
Rivaroxaban—Oropharyngeal pain—Lomustine—brain cancer	0.00715	0.0243	CcSEcCtD
Rivaroxaban—CYP2J2—Arachidonic acid metabolism—CYP2C9—brain cancer	0.00632	0.0442	CbGpPWpGaD
Rivaroxaban—Haemorrhage intracranial—Temozolomide—brain cancer	0.00609	0.0207	CcSEcCtD
Rivaroxaban—Haemoptysis—Procarbazine—brain cancer	0.00558	0.0189	CcSEcCtD
Rivaroxaban—CYP2J2—Cytochrome P450 - arranged by substrate type—CYP2C9—brain cancer	0.00546	0.0382	CbGpPWpGaD
Rivaroxaban—CYP2J2—Oxidation by Cytochrome P450—CYP2C9—brain cancer	0.00539	0.0377	CbGpPWpGaD
Rivaroxaban—Osteoarthritis—Lomustine—brain cancer	0.00472	0.016	CcSEcCtD
Rivaroxaban—Cerebral haemorrhage—Carmustine—brain cancer	0.00467	0.0158	CcSEcCtD
Rivaroxaban—Cerebral haemorrhage—Temozolomide—brain cancer	0.00451	0.0153	CcSEcCtD
Rivaroxaban—Blister—Hydroxyurea—brain cancer	0.00443	0.015	CcSEcCtD
Rivaroxaban—CYP2J2—Phase 1 - Functionalization of compounds—CYP2C9—brain cancer	0.00443	0.031	CbGpPWpGaD
Rivaroxaban—CYP2J2—blood vessel—brain cancer	0.00433	0.161	CbGeAlD
Rivaroxaban—CYP3A5—Xenobiotics—CYP2C9—brain cancer	0.00379	0.0265	CbGpPWpGaD
Rivaroxaban—CYP3A5—Tamoxifen metabolism—CYP2C9—brain cancer	0.00365	0.0255	CbGpPWpGaD
Rivaroxaban—Renal failure—Lomustine—brain cancer	0.00358	0.0121	CcSEcCtD
Rivaroxaban—Hepatic function abnormal—Procarbazine—brain cancer	0.00343	0.0116	CcSEcCtD
Rivaroxaban—Menorrhagia—Temozolomide—brain cancer	0.00337	0.0114	CcSEcCtD
Rivaroxaban—Cholestasis—Temozolomide—brain cancer	0.00329	0.0112	CcSEcCtD
Rivaroxaban—Haemoglobin—Lomustine—brain cancer	0.00328	0.0111	CcSEcCtD
Rivaroxaban—Haemorrhage—Lomustine—brain cancer	0.00327	0.0111	CcSEcCtD
Rivaroxaban—Gamma-glutamyltransferase increased—Temozolomide—brain cancer	0.00304	0.0103	CcSEcCtD
Rivaroxaban—Blood urea increased—Hydroxyurea—brain cancer	0.00302	0.0102	CcSEcCtD
Rivaroxaban—Infection—Carboplatin—brain cancer	0.00264	0.00894	CcSEcCtD
Rivaroxaban—CYP3A5—Constitutive Androstane Receptor Pathway—CYP2C9—brain cancer	0.0026	0.0182	CbGpPWpGaD
Rivaroxaban—Angina pectoris—Procarbazine—brain cancer	0.00252	0.00856	CcSEcCtD
Rivaroxaban—Renal failure acute—Hydroxyurea—brain cancer	0.00251	0.00853	CcSEcCtD
Rivaroxaban—Dermatitis bullous—Hydroxyurea—brain cancer	0.00243	0.00824	CcSEcCtD
Rivaroxaban—CYP2J2—Biological oxidations—CYP2C9—brain cancer	0.00235	0.0165	CbGpPWpGaD
Rivaroxaban—CYP2J2—Metapathway biotransformation—CYP2C9—brain cancer	0.00232	0.0162	CbGpPWpGaD
Rivaroxaban—Infection—Lomustine—brain cancer	0.00231	0.00782	CcSEcCtD
Rivaroxaban—Pain—Carboplatin—brain cancer	0.00227	0.0077	CcSEcCtD
Rivaroxaban—Jaundice—Procarbazine—brain cancer	0.00225	0.00764	CcSEcCtD
Rivaroxaban—Haematuria—Procarbazine—brain cancer	0.0022	0.00747	CcSEcCtD
Rivaroxaban—Epistaxis—Procarbazine—brain cancer	0.00218	0.00739	CcSEcCtD
Rivaroxaban—Blood creatinine increased—Hydroxyurea—brain cancer	0.00217	0.00738	CcSEcCtD
Rivaroxaban—Swelling—Carmustine—brain cancer	0.00213	0.00721	CcSEcCtD
Rivaroxaban—CYP2J2—telencephalon—brain cancer	0.0021	0.0781	CbGeAlD
Rivaroxaban—Haemoglobin—Procarbazine—brain cancer	0.00208	0.00707	CcSEcCtD
Rivaroxaban—Haemorrhage—Procarbazine—brain cancer	0.00207	0.00704	CcSEcCtD
Rivaroxaban—ABCB1—Constitutive Androstane Receptor Pathway—CYP2C9—brain cancer	0.00197	0.0138	CbGpPWpGaD
Rivaroxaban—Gastrointestinal haemorrhage—Carmustine—brain cancer	0.00188	0.00636	CcSEcCtD
Rivaroxaban—ABCB1—Nuclear Receptors in Lipid Metabolism and Toxicity—CYP2C9—brain cancer	0.00187	0.0131	CbGpPWpGaD
Rivaroxaban—Infestation—Hydroxyurea—brain cancer	0.00179	0.00607	CcSEcCtD
Rivaroxaban—Infestation NOS—Hydroxyurea—brain cancer	0.00179	0.00607	CcSEcCtD
Rivaroxaban—CYP3A4—Xenobiotics—CYP2C9—brain cancer	0.00176	0.0123	CbGpPWpGaD
Rivaroxaban—CYP2J2—pituitary gland—brain cancer	0.00171	0.0636	CbGeAlD
Rivaroxaban—CYP3A4—Tamoxifen metabolism—CYP2C9—brain cancer	0.0017	0.0119	CbGpPWpGaD
Rivaroxaban—Hepatobiliary disease—Hydroxyurea—brain cancer	0.00169	0.00574	CcSEcCtD
Rivaroxaban—Anaemia—Procarbazine—brain cancer	0.00167	0.00566	CcSEcCtD
Rivaroxaban—CYP2J2—medulla oblongata—brain cancer	0.00165	0.0614	CbGeAlD
Rivaroxaban—Swelling—Etoposide—brain cancer	0.00164	0.00558	CcSEcCtD
Rivaroxaban—Syncope—Procarbazine—brain cancer	0.00162	0.00549	CcSEcCtD
Rivaroxaban—F10—endocrine gland—brain cancer	0.00162	0.0601	CbGeAlD
Rivaroxaban—Haemoglobin—Hydroxyurea—brain cancer	0.00161	0.00547	CcSEcCtD
Rivaroxaban—Haemorrhage—Hydroxyurea—brain cancer	0.00161	0.00545	CcSEcCtD
Rivaroxaban—F10—head—brain cancer	0.0016	0.0594	CbGeAlD
Rivaroxaban—Loss of consciousness—Procarbazine—brain cancer	0.00159	0.00538	CcSEcCtD
Rivaroxaban—CYP3A5—Cytochrome P450 - arranged by substrate type—CYP2C9—brain cancer	0.00157	0.011	CbGpPWpGaD
Rivaroxaban—CYP3A5—Oxidation by Cytochrome P450—CYP2C9—brain cancer	0.00155	0.0109	CbGpPWpGaD
Rivaroxaban—CYP2J2—midbrain—brain cancer	0.00151	0.0561	CbGeAlD
Rivaroxaban—Dry mouth—Procarbazine—brain cancer	0.0015	0.0051	CcSEcCtD
Rivaroxaban—Vomiting—Lomustine—brain cancer	0.00148	0.00501	CcSEcCtD
Rivaroxaban—Oedema—Procarbazine—brain cancer	0.00147	0.005	CcSEcCtD
Rivaroxaban—CYP2J2—spinal cord—brain cancer	0.00147	0.0547	CbGeAlD
Rivaroxaban—Infection—Procarbazine—brain cancer	0.00146	0.00497	CcSEcCtD
Rivaroxaban—Angiopathy—Hydroxyurea—brain cancer	0.00146	0.00494	CcSEcCtD
Rivaroxaban—Shock—Procarbazine—brain cancer	0.00145	0.00492	CcSEcCtD
Rivaroxaban—Tachycardia—Procarbazine—brain cancer	0.00144	0.00488	CcSEcCtD
Rivaroxaban—Renal failure—Carmustine—brain cancer	0.00142	0.00482	CcSEcCtD
Rivaroxaban—Urinary tract infection—Carmustine—brain cancer	0.00141	0.00477	CcSEcCtD
Rivaroxaban—Infestation—Temozolomide—brain cancer	0.0014	0.00474	CcSEcCtD
Rivaroxaban—Infestation NOS—Temozolomide—brain cancer	0.0014	0.00474	CcSEcCtD
Rivaroxaban—Stevens-Johnson syndrome—Temozolomide—brain cancer	0.00138	0.0047	CcSEcCtD
Rivaroxaban—Nausea—Lomustine—brain cancer	0.00138	0.00468	CcSEcCtD
Rivaroxaban—Hypotension—Procarbazine—brain cancer	0.00138	0.00467	CcSEcCtD
Rivaroxaban—Urinary tract infection—Temozolomide—brain cancer	0.00136	0.00461	CcSEcCtD
Rivaroxaban—CYP3A5—Irinotecan Pathway—APC—brain cancer	0.00134	0.00936	CbGpPWpGaD
Rivaroxaban—CYP2J2—endocrine gland—brain cancer	0.00133	0.0493	CbGeAlD
Rivaroxaban—Hepatobiliary disease—Temozolomide—brain cancer	0.00132	0.00448	CcSEcCtD
Rivaroxaban—Sinusitis—Temozolomide—brain cancer	0.00131	0.00445	CcSEcCtD
Rivaroxaban—CYP2J2—head—brain cancer	0.00131	0.0487	CbGeAlD
Rivaroxaban—Haemoglobin—Carmustine—brain cancer	0.0013	0.00442	CcSEcCtD
Rivaroxaban—Haemorrhage—Carmustine—brain cancer	0.0013	0.0044	CcSEcCtD
Rivaroxaban—Ill-defined disorder—Hydroxyurea—brain cancer	0.0013	0.0044	CcSEcCtD
Rivaroxaban—Anaemia—Hydroxyurea—brain cancer	0.00129	0.00438	CcSEcCtD
Rivaroxaban—CYP3A5—Phase 1 - Functionalization of compounds—CYP2C9—brain cancer	0.00128	0.00893	CbGpPWpGaD
Rivaroxaban—Connective tissue disorder—Carmustine—brain cancer	0.00128	0.00433	CcSEcCtD
Rivaroxaban—Fatigue—Procarbazine—brain cancer	0.00127	0.00431	CcSEcCtD
Rivaroxaban—F10—Hemostasis—MPL—brain cancer	0.00127	0.00888	CbGpPWpGaD
Rivaroxaban—Haemoglobin—Temozolomide—brain cancer	0.00126	0.00428	CcSEcCtD
Rivaroxaban—Malaise—Hydroxyurea—brain cancer	0.00126	0.00428	CcSEcCtD
Rivaroxaban—Pain—Procarbazine—brain cancer	0.00126	0.00428	CcSEcCtD
Rivaroxaban—Constipation—Procarbazine—brain cancer	0.00126	0.00428	CcSEcCtD
Rivaroxaban—Haemorrhage—Temozolomide—brain cancer	0.00125	0.00425	CcSEcCtD
Rivaroxaban—Hepatitis—Temozolomide—brain cancer	0.00125	0.00425	CcSEcCtD
Rivaroxaban—Urinary tract disorder—Temozolomide—brain cancer	0.00124	0.0042	CcSEcCtD
Rivaroxaban—Connective tissue disorder—Temozolomide—brain cancer	0.00123	0.00418	CcSEcCtD
Rivaroxaban—Urethral disorder—Temozolomide—brain cancer	0.00123	0.00417	CcSEcCtD
Rivaroxaban—F10—Hemostasis—S100A10—brain cancer	0.00122	0.00851	CbGpPWpGaD
Rivaroxaban—Feeling abnormal—Procarbazine—brain cancer	0.00121	0.00412	CcSEcCtD
Rivaroxaban—Eye disorder—Carmustine—brain cancer	0.00121	0.00411	CcSEcCtD
Rivaroxaban—CYP3A4—Constitutive Androstane Receptor Pathway—CYP2C9—brain cancer	0.00121	0.00847	CbGpPWpGaD
Rivaroxaban—Gastrointestinal pain—Procarbazine—brain cancer	0.00121	0.00409	CcSEcCtD
Rivaroxaban—CYP2J2—central nervous system—brain cancer	0.00119	0.0444	CbGeAlD
Rivaroxaban—Erythema multiforme—Temozolomide—brain cancer	0.00119	0.00402	CcSEcCtD
Rivaroxaban—Unspecified disorder of skin and subcutaneous tissue—Hydroxyurea—brain cancer	0.00118	0.00401	CcSEcCtD
Rivaroxaban—Discomfort—Hydroxyurea—brain cancer	0.00118	0.00399	CcSEcCtD
Rivaroxaban—Eye disorder—Temozolomide—brain cancer	0.00117	0.00398	CcSEcCtD
Rivaroxaban—Urticaria—Procarbazine—brain cancer	0.00117	0.00397	CcSEcCtD
Rivaroxaban—CYP2J2—cerebellum—brain cancer	0.00117	0.0434	CbGeAlD
Rivaroxaban—Abdominal pain—Procarbazine—brain cancer	0.00116	0.00395	CcSEcCtD
Rivaroxaban—Cardiac disorder—Temozolomide—brain cancer	0.00116	0.00395	CcSEcCtD
Rivaroxaban—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—CYP2C9—brain cancer	0.00115	0.00807	CbGpPWpGaD
Rivaroxaban—Oedema—Hydroxyurea—brain cancer	0.00114	0.00387	CcSEcCtD
Rivaroxaban—Angiopathy—Temozolomide—brain cancer	0.00114	0.00386	CcSEcCtD
Rivaroxaban—Infection—Hydroxyurea—brain cancer	0.00113	0.00384	CcSEcCtD
Rivaroxaban—Immune system disorder—Temozolomide—brain cancer	0.00113	0.00384	CcSEcCtD
Rivaroxaban—Mediastinal disorder—Temozolomide—brain cancer	0.00113	0.00383	CcSEcCtD
Rivaroxaban—Nervous system disorder—Hydroxyurea—brain cancer	0.00112	0.00379	CcSEcCtD
Rivaroxaban—Infestation NOS—Etoposide—brain cancer	0.00112	0.00379	CcSEcCtD
Rivaroxaban—Infestation—Etoposide—brain cancer	0.00112	0.00379	CcSEcCtD
Rivaroxaban—Stevens-Johnson syndrome—Etoposide—brain cancer	0.00111	0.00376	CcSEcCtD
Rivaroxaban—Skin disorder—Hydroxyurea—brain cancer	0.00111	0.00376	CcSEcCtD
Rivaroxaban—Renal failure—Etoposide—brain cancer	0.0011	0.00373	CcSEcCtD
Rivaroxaban—Back pain—Carmustine—brain cancer	0.00109	0.00371	CcSEcCtD
Rivaroxaban—Jaundice—Etoposide—brain cancer	0.00109	0.0037	CcSEcCtD
Rivaroxaban—Hypersensitivity—Procarbazine—brain cancer	0.00109	0.00368	CcSEcCtD
Rivaroxaban—Asthenia—Procarbazine—brain cancer	0.00106	0.00359	CcSEcCtD
Rivaroxaban—Hepatobiliary disease—Etoposide—brain cancer	0.00106	0.00359	CcSEcCtD
Rivaroxaban—Back pain—Temozolomide—brain cancer	0.00106	0.00358	CcSEcCtD
Rivaroxaban—Anaemia—Carmustine—brain cancer	0.00104	0.00354	CcSEcCtD
Rivaroxaban—Agranulocytosis—Etoposide—brain cancer	0.00104	0.00354	CcSEcCtD
Rivaroxaban—Pruritus—Procarbazine—brain cancer	0.00104	0.00354	CcSEcCtD
Rivaroxaban—Dyspnoea—Hydroxyurea—brain cancer	0.00102	0.00345	CcSEcCtD
Rivaroxaban—Ill-defined disorder—Temozolomide—brain cancer	0.00101	0.00344	CcSEcCtD
Rivaroxaban—Anaemia—Temozolomide—brain cancer	0.00101	0.00342	CcSEcCtD
Rivaroxaban—Diarrhoea—Procarbazine—brain cancer	0.00101	0.00342	CcSEcCtD
Rivaroxaban—Dyspepsia—Hydroxyurea—brain cancer	0.001	0.00341	CcSEcCtD
Rivaroxaban—Angioedema—Temozolomide—brain cancer	0.000998	0.00338	CcSEcCtD
Rivaroxaban—Urinary tract disorder—Etoposide—brain cancer	0.000991	0.00336	CcSEcCtD
Rivaroxaban—Gastrointestinal disorder—Hydroxyurea—brain cancer	0.000985	0.00334	CcSEcCtD
Rivaroxaban—Malaise—Temozolomide—brain cancer	0.000984	0.00334	CcSEcCtD
Rivaroxaban—Urethral disorder—Etoposide—brain cancer	0.000984	0.00334	CcSEcCtD
Rivaroxaban—Fatigue—Hydroxyurea—brain cancer	0.000983	0.00334	CcSEcCtD
Rivaroxaban—Pain—Hydroxyurea—brain cancer	0.000975	0.00331	CcSEcCtD
Rivaroxaban—Constipation—Hydroxyurea—brain cancer	0.000975	0.00331	CcSEcCtD
Rivaroxaban—Dizziness—Procarbazine—brain cancer	0.000974	0.00331	CcSEcCtD
Rivaroxaban—Chest pain—Carmustine—brain cancer	0.000962	0.00326	CcSEcCtD
Rivaroxaban—Erythema multiforme—Etoposide—brain cancer	0.000949	0.00322	CcSEcCtD
Rivaroxaban—CYP2J2—brain—brain cancer	0.000948	0.0353	CbGeAlD
Rivaroxaban—Feeling abnormal—Hydroxyurea—brain cancer	0.00094	0.00319	CcSEcCtD
Rivaroxaban—Eye disorder—Etoposide—brain cancer	0.000938	0.00318	CcSEcCtD
Rivaroxaban—Vomiting—Procarbazine—brain cancer	0.000937	0.00318	CcSEcCtD
Rivaroxaban—Cardiac disorder—Etoposide—brain cancer	0.000931	0.00316	CcSEcCtD
Rivaroxaban—Rash—Procarbazine—brain cancer	0.000929	0.00315	CcSEcCtD
Rivaroxaban—Dermatitis—Procarbazine—brain cancer	0.000928	0.00315	CcSEcCtD
Rivaroxaban—Headache—Procarbazine—brain cancer	0.000923	0.00313	CcSEcCtD
Rivaroxaban—Unspecified disorder of skin and subcutaneous tissue—Temozolomide—brain cancer	0.000923	0.00313	CcSEcCtD
Rivaroxaban—Oedema—Carmustine—brain cancer	0.000922	0.00313	CcSEcCtD
Rivaroxaban—Discomfort—Temozolomide—brain cancer	0.000918	0.00312	CcSEcCtD
Rivaroxaban—Infection—Carmustine—brain cancer	0.000916	0.00311	CcSEcCtD
Rivaroxaban—Angiopathy—Etoposide—brain cancer	0.00091	0.00309	CcSEcCtD
Rivaroxaban—Dry mouth—Temozolomide—brain cancer	0.000909	0.00308	CcSEcCtD
Rivaroxaban—Immune system disorder—Etoposide—brain cancer	0.000906	0.00308	CcSEcCtD
Rivaroxaban—Mediastinal disorder—Etoposide—brain cancer	0.000904	0.00307	CcSEcCtD
Rivaroxaban—CYP2J2—Metabolism of lipids and lipoproteins—CYP2C9—brain cancer	0.000904	0.00632	CbGpPWpGaD
Rivaroxaban—Tachycardia—Carmustine—brain cancer	0.0009	0.00305	CcSEcCtD
Rivaroxaban—Oedema—Temozolomide—brain cancer	0.000891	0.00302	CcSEcCtD
Rivaroxaban—Anaphylactic shock—Temozolomide—brain cancer	0.000891	0.00302	CcSEcCtD
Rivaroxaban—Infection—Temozolomide—brain cancer	0.000885	0.003	CcSEcCtD
Rivaroxaban—Nausea—Procarbazine—brain cancer	0.000875	0.00297	CcSEcCtD
Rivaroxaban—Nervous system disorder—Temozolomide—brain cancer	0.000874	0.00296	CcSEcCtD
Rivaroxaban—Skin disorder—Temozolomide—brain cancer	0.000865	0.00294	CcSEcCtD
Rivaroxaban—Hypotension—Carmustine—brain cancer	0.000862	0.00292	CcSEcCtD
Rivaroxaban—F10—Hemostasis—BSG—brain cancer	0.000857	0.006	CbGpPWpGaD
Rivaroxaban—Back pain—Etoposide—brain cancer	0.000845	0.00287	CcSEcCtD
Rivaroxaban—Hypersensitivity—Hydroxyurea—brain cancer	0.00084	0.00285	CcSEcCtD
Rivaroxaban—Muscle spasms—Etoposide—brain cancer	0.00084	0.00285	CcSEcCtD
Rivaroxaban—Dyspnoea—Carmustine—brain cancer	0.000822	0.00279	CcSEcCtD
Rivaroxaban—Asthenia—Hydroxyurea—brain cancer	0.000818	0.00278	CcSEcCtD
Rivaroxaban—Ill-defined disorder—Etoposide—brain cancer	0.000811	0.00275	CcSEcCtD
Rivaroxaban—ABCB1—blood vessel—brain cancer	0.00081	0.0301	CbGeAlD
Rivaroxaban—Anaemia—Etoposide—brain cancer	0.000807	0.00274	CcSEcCtD
Rivaroxaban—Gastrointestinal disorder—Carmustine—brain cancer	0.000796	0.0027	CcSEcCtD
Rivaroxaban—Dyspnoea—Temozolomide—brain cancer	0.000794	0.00269	CcSEcCtD
Rivaroxaban—Pain—Carmustine—brain cancer	0.000788	0.00267	CcSEcCtD
Rivaroxaban—Constipation—Carmustine—brain cancer	0.000788	0.00267	CcSEcCtD
Rivaroxaban—Malaise—Etoposide—brain cancer	0.000788	0.00267	CcSEcCtD
Rivaroxaban—Dyspepsia—Temozolomide—brain cancer	0.000784	0.00266	CcSEcCtD
Rivaroxaban—Diarrhoea—Hydroxyurea—brain cancer	0.00078	0.00265	CcSEcCtD
Rivaroxaban—Gastrointestinal disorder—Temozolomide—brain cancer	0.000769	0.00261	CcSEcCtD
Rivaroxaban—Fatigue—Temozolomide—brain cancer	0.000768	0.00261	CcSEcCtD
Rivaroxaban—Loss of consciousness—Etoposide—brain cancer	0.000768	0.0026	CcSEcCtD
Rivaroxaban—ABCB1—Imatinib Resistance in Chronic Myeloid Leukemia—SKP2—brain cancer	0.000766	0.00536	CbGpPWpGaD
Rivaroxaban—Pain—Temozolomide—brain cancer	0.000762	0.00258	CcSEcCtD
Rivaroxaban—Constipation—Temozolomide—brain cancer	0.000762	0.00258	CcSEcCtD
Rivaroxaban—Feeling abnormal—Carmustine—brain cancer	0.00076	0.00258	CcSEcCtD
Rivaroxaban—Dizziness—Hydroxyurea—brain cancer	0.000754	0.00256	CcSEcCtD
Rivaroxaban—Gastrointestinal pain—Carmustine—brain cancer	0.000754	0.00256	CcSEcCtD
Rivaroxaban—Chest pain—Etoposide—brain cancer	0.000744	0.00252	CcSEcCtD
Rivaroxaban—Unspecified disorder of skin and subcutaneous tissue—Etoposide—brain cancer	0.000739	0.00251	CcSEcCtD
Rivaroxaban—Discomfort—Etoposide—brain cancer	0.000735	0.00249	CcSEcCtD
Rivaroxaban—Feeling abnormal—Temozolomide—brain cancer	0.000734	0.00249	CcSEcCtD
Rivaroxaban—CYP3A4—Cytochrome P450 - arranged by substrate type—CYP2C9—brain cancer	0.000732	0.00512	CbGpPWpGaD
Rivaroxaban—Abdominal pain—Carmustine—brain cancer	0.000729	0.00247	CcSEcCtD
Rivaroxaban—Gastrointestinal pain—Temozolomide—brain cancer	0.000729	0.00247	CcSEcCtD
Rivaroxaban—Vomiting—Hydroxyurea—brain cancer	0.000725	0.00246	CcSEcCtD
Rivaroxaban—CYP3A4—Oxidation by Cytochrome P450—CYP2C9—brain cancer	0.000723	0.00506	CbGpPWpGaD
Rivaroxaban—Rash—Hydroxyurea—brain cancer	0.000719	0.00244	CcSEcCtD
Rivaroxaban—Dermatitis—Hydroxyurea—brain cancer	0.000718	0.00244	CcSEcCtD
Rivaroxaban—Headache—Hydroxyurea—brain cancer	0.000714	0.00242	CcSEcCtD
Rivaroxaban—Anaphylactic shock—Etoposide—brain cancer	0.000713	0.00242	CcSEcCtD
Rivaroxaban—Infection—Etoposide—brain cancer	0.000708	0.0024	CcSEcCtD
Rivaroxaban—Urticaria—Temozolomide—brain cancer	0.000708	0.0024	CcSEcCtD
Rivaroxaban—Abdominal pain—Temozolomide—brain cancer	0.000704	0.00239	CcSEcCtD
Rivaroxaban—Tachycardia—Etoposide—brain cancer	0.000696	0.00236	CcSEcCtD
Rivaroxaban—Skin disorder—Etoposide—brain cancer	0.000693	0.00235	CcSEcCtD
Rivaroxaban—ABCB1—Imatinib Resistance in Chronic Myeloid Leukemia—CDK6—brain cancer	0.000682	0.00478	CbGpPWpGaD
Rivaroxaban—Hypersensitivity—Carmustine—brain cancer	0.000679	0.0023	CcSEcCtD
Rivaroxaban—CYP3A5—Biological oxidations—CYP2C9—brain cancer	0.000678	0.00475	CbGpPWpGaD
Rivaroxaban—Nausea—Hydroxyurea—brain cancer	0.000677	0.0023	CcSEcCtD
Rivaroxaban—CYP3A5—Metapathway biotransformation—CYP2C9—brain cancer	0.000669	0.00468	CbGpPWpGaD
Rivaroxaban—Hypotension—Etoposide—brain cancer	0.000666	0.00226	CcSEcCtD
Rivaroxaban—Asthenia—Carmustine—brain cancer	0.000661	0.00224	CcSEcCtD
Rivaroxaban—CYP2J2—Metabolism of lipids and lipoproteins—IDH1—brain cancer	0.000661	0.00462	CbGpPWpGaD
Rivaroxaban—Hypersensitivity—Temozolomide—brain cancer	0.000656	0.00223	CcSEcCtD
Rivaroxaban—Asthenia—Temozolomide—brain cancer	0.000639	0.00217	CcSEcCtD
Rivaroxaban—Dyspnoea—Etoposide—brain cancer	0.000636	0.00216	CcSEcCtD
Rivaroxaban—Diarrhoea—Carmustine—brain cancer	0.000631	0.00214	CcSEcCtD
Rivaroxaban—Pruritus—Temozolomide—brain cancer	0.00063	0.00214	CcSEcCtD
Rivaroxaban—CYP3A4—Irinotecan Pathway—APC—brain cancer	0.000622	0.00435	CbGpPWpGaD
Rivaroxaban—Gastrointestinal disorder—Etoposide—brain cancer	0.000616	0.00209	CcSEcCtD
Rivaroxaban—Fatigue—Etoposide—brain cancer	0.000615	0.00209	CcSEcCtD
Rivaroxaban—Dizziness—Carmustine—brain cancer	0.00061	0.00207	CcSEcCtD
Rivaroxaban—Constipation—Etoposide—brain cancer	0.00061	0.00207	CcSEcCtD
Rivaroxaban—Pain—Etoposide—brain cancer	0.00061	0.00207	CcSEcCtD
Rivaroxaban—Diarrhoea—Temozolomide—brain cancer	0.00061	0.00207	CcSEcCtD
Rivaroxaban—CYP3A4—Phase 1 - Functionalization of compounds—CYP2C9—brain cancer	0.000594	0.00415	CbGpPWpGaD
Rivaroxaban—Dizziness—Temozolomide—brain cancer	0.000589	0.002	CcSEcCtD
Rivaroxaban—Feeling abnormal—Etoposide—brain cancer	0.000588	0.00199	CcSEcCtD
Rivaroxaban—Vomiting—Carmustine—brain cancer	0.000586	0.00199	CcSEcCtD
Rivaroxaban—Gastrointestinal pain—Etoposide—brain cancer	0.000583	0.00198	CcSEcCtD
Rivaroxaban—Rash—Carmustine—brain cancer	0.000581	0.00197	CcSEcCtD
Rivaroxaban—Dermatitis—Carmustine—brain cancer	0.000581	0.00197	CcSEcCtD
Rivaroxaban—Headache—Carmustine—brain cancer	0.000578	0.00196	CcSEcCtD
Rivaroxaban—Vomiting—Temozolomide—brain cancer	0.000566	0.00192	CcSEcCtD
Rivaroxaban—Urticaria—Etoposide—brain cancer	0.000566	0.00192	CcSEcCtD
Rivaroxaban—Abdominal pain—Etoposide—brain cancer	0.000564	0.00191	CcSEcCtD
Rivaroxaban—F10—Hemostasis—TRPC6—brain cancer	0.000562	0.00393	CbGpPWpGaD
Rivaroxaban—Rash—Temozolomide—brain cancer	0.000562	0.00191	CcSEcCtD
Rivaroxaban—Dermatitis—Temozolomide—brain cancer	0.000561	0.0019	CcSEcCtD
Rivaroxaban—Headache—Temozolomide—brain cancer	0.000558	0.00189	CcSEcCtD
Rivaroxaban—CYP3A4—Farnesoid X Receptor  Pathway—IRS2—brain cancer	0.000552	0.00386	CbGpPWpGaD
Rivaroxaban—Nausea—Carmustine—brain cancer	0.000548	0.00186	CcSEcCtD
Rivaroxaban—Nausea—Temozolomide—brain cancer	0.000529	0.0018	CcSEcCtD
Rivaroxaban—Hypersensitivity—Etoposide—brain cancer	0.000525	0.00178	CcSEcCtD
Rivaroxaban—Asthenia—Etoposide—brain cancer	0.000512	0.00174	CcSEcCtD
Rivaroxaban—Pruritus—Etoposide—brain cancer	0.000504	0.00171	CcSEcCtD
Rivaroxaban—Diarrhoea—Etoposide—brain cancer	0.000488	0.00165	CcSEcCtD
Rivaroxaban—ABCB1—Imatinib Resistance in Chronic Myeloid Leukemia—PDGFRA—brain cancer	0.000478	0.00334	CbGpPWpGaD
Rivaroxaban—Dizziness—Etoposide—brain cancer	0.000471	0.0016	CcSEcCtD
Rivaroxaban—CYP3A5—endocrine gland—brain cancer	0.000466	0.0173	CbGeAlD
Rivaroxaban—Vomiting—Etoposide—brain cancer	0.000453	0.00154	CcSEcCtD
Rivaroxaban—Rash—Etoposide—brain cancer	0.00045	0.00153	CcSEcCtD
Rivaroxaban—Dermatitis—Etoposide—brain cancer	0.000449	0.00152	CcSEcCtD
Rivaroxaban—Headache—Etoposide—brain cancer	0.000447	0.00152	CcSEcCtD
Rivaroxaban—Nausea—Etoposide—brain cancer	0.000423	0.00144	CcSEcCtD
Rivaroxaban—F10—Hemostasis—VAV1—brain cancer	0.000421	0.00295	CbGpPWpGaD
Rivaroxaban—CYP2J2—Metabolism—CYP2C9—brain cancer	0.000402	0.00282	CbGpPWpGaD
Rivaroxaban—ABCB1—telencephalon—brain cancer	0.000393	0.0146	CbGeAlD
Rivaroxaban—CYP3A4—endocrine gland—brain cancer	0.00035	0.013	CbGeAlD
Rivaroxaban—CYP2J2—Metabolism—BSG—brain cancer	0.000342	0.00239	CbGpPWpGaD
Rivaroxaban—ABCB1—gonad—brain cancer	0.000328	0.0122	CbGeAlD
Rivaroxaban—ABCB1—Allograft Rejection—PDGFRA—brain cancer	0.000326	0.00228	CbGpPWpGaD
Rivaroxaban—ABCB1—pituitary gland—brain cancer	0.00032	0.0119	CbGeAlD
Rivaroxaban—CYP3A4—central nervous system—brain cancer	0.000315	0.0117	CbGeAlD
Rivaroxaban—CYP3A4—Biological oxidations—CYP2C9—brain cancer	0.000315	0.00221	CbGpPWpGaD
Rivaroxaban—CYP3A4—Metapathway biotransformation—CYP2C9—brain cancer	0.000311	0.00218	CbGpPWpGaD
Rivaroxaban—ABCB1—medulla oblongata—brain cancer	0.000309	0.0115	CbGeAlD
Rivaroxaban—CYP2J2—Metabolism—IDH1—brain cancer	0.000294	0.00206	CbGpPWpGaD
Rivaroxaban—ABCB1—midbrain—brain cancer	0.000282	0.0105	CbGeAlD
Rivaroxaban—ABCB1—spinal cord—brain cancer	0.000275	0.0102	CbGeAlD
Rivaroxaban—ABCB1—Integrated Pancreatic Cancer Pathway—SHH—brain cancer	0.000272	0.0019	CbGpPWpGaD
Rivaroxaban—F10—Hemostasis—PIK3CG—brain cancer	0.000267	0.00187	CbGpPWpGaD
Rivaroxaban—ABCB1—Integrated Pancreatic Cancer Pathway—SMO—brain cancer	0.000258	0.0018	CbGpPWpGaD
Rivaroxaban—ABCB1—endocrine gland—brain cancer	0.000248	0.00921	CbGeAlD
Rivaroxaban—ABCB1—head—brain cancer	0.000245	0.0091	CbGeAlD
Rivaroxaban—CYP2J2—Metabolism of lipids and lipoproteins—PIK3CG—brain cancer	0.00024	0.00168	CbGpPWpGaD
Rivaroxaban—CYP2J2—Metabolism—ENO2—brain cancer	0.000233	0.00163	CbGpPWpGaD
Rivaroxaban—ABCB1—Transmembrane transport of small molecules—S100A10—brain cancer	0.000226	0.00158	CbGpPWpGaD
Rivaroxaban—ABCB1—central nervous system—brain cancer	0.000223	0.0083	CbGeAlD
Rivaroxaban—ABCB1—cerebellum—brain cancer	0.000218	0.00812	CbGeAlD
Rivaroxaban—ABCB1—Integrated Pancreatic Cancer Pathway—ESR2—brain cancer	0.000218	0.00152	CbGpPWpGaD
Rivaroxaban—ABCB1—Imatinib Resistance in Chronic Myeloid Leukemia—MYC—brain cancer	0.000204	0.00143	CbGpPWpGaD
Rivaroxaban—F10—Hemostasis—IL2—brain cancer	0.000188	0.00132	CbGpPWpGaD
Rivaroxaban—ABCB1—Integrated Pancreatic Cancer Pathway—BRCA2—brain cancer	0.000179	0.00125	CbGpPWpGaD
Rivaroxaban—ABCB1—Allograft Rejection—IL2—brain cancer	0.000178	0.00125	CbGpPWpGaD
Rivaroxaban—ABCB1—brain—brain cancer	0.000177	0.00659	CbGeAlD
Rivaroxaban—ABCB1—Integrated Pancreatic Cancer Pathway—SIRT1—brain cancer	0.000175	0.00123	CbGpPWpGaD
Rivaroxaban—ABCB1—HIF-1-alpha transcription factor network—VEGFA—brain cancer	0.000175	0.00122	CbGpPWpGaD
Rivaroxaban—ABCB1—Integrated Pancreatic Cancer Pathway—CCNE1—brain cancer	0.000173	0.00121	CbGpPWpGaD
Rivaroxaban—ABCB1—Integrated Pancreatic Cancer Pathway—PDGFRA—brain cancer	0.000161	0.00113	CbGpPWpGaD
Rivaroxaban—F10—Hemostasis—VEGFA—brain cancer	0.00016	0.00112	CbGpPWpGaD
Rivaroxaban—ABCB1—Integrated Pancreatic Cancer Pathway—PCNA—brain cancer	0.000153	0.00107	CbGpPWpGaD
Rivaroxaban—ABCB1—Allograft Rejection—VEGFA—brain cancer	0.000151	0.00106	CbGpPWpGaD
Rivaroxaban—F10—Metabolism of proteins—CTNNB1—brain cancer	0.000143	0.001	CbGpPWpGaD
Rivaroxaban—ABCB1—Integrated Pancreatic Cancer Pathway—CDK4—brain cancer	0.000133	0.000928	CbGpPWpGaD
Rivaroxaban—ABCB1—Integrated Pancreatic Cancer Pathway—APC—brain cancer	0.000125	0.000873	CbGpPWpGaD
Rivaroxaban—F10—Hemostasis—TP53—brain cancer	0.000121	0.000845	CbGpPWpGaD
Rivaroxaban—CYP3A5—Metabolism—CYP2C9—brain cancer	0.000116	0.000812	CbGpPWpGaD
Rivaroxaban—CYP2J2—Metabolism—PIK3CG—brain cancer	0.000107	0.000747	CbGpPWpGaD
Rivaroxaban—ABCB1—Transmembrane transport of small molecules—TRPC6—brain cancer	0.000104	0.000729	CbGpPWpGaD
Rivaroxaban—CYP3A5—Metabolism—BSG—brain cancer	9.86e-05	0.00069	CbGpPWpGaD
Rivaroxaban—ABCB1—Integrated Pancreatic Cancer Pathway—ERBB2—brain cancer	9.69e-05	0.000678	CbGpPWpGaD
Rivaroxaban—ABCB1—Metabolism—CYP2C9—brain cancer	8.75e-05	0.000612	CbGpPWpGaD
Rivaroxaban—ABCB1—Integrated Pancreatic Cancer Pathway—CCND1—brain cancer	8.56e-05	0.000599	CbGpPWpGaD
Rivaroxaban—CYP3A5—Metabolism—IDH1—brain cancer	8.48e-05	0.000593	CbGpPWpGaD
Rivaroxaban—ABCB1—Integrated Pancreatic Cancer Pathway—CTNNB1—brain cancer	8.48e-05	0.000593	CbGpPWpGaD
Rivaroxaban—ABCB1—Integrated Pancreatic Cancer Pathway—VEGFA—brain cancer	7.46e-05	0.000522	CbGpPWpGaD
Rivaroxaban—ABCB1—Metabolism—BSG—brain cancer	7.44e-05	0.000521	CbGpPWpGaD
Rivaroxaban—ABCB1—Integrated Pancreatic Cancer Pathway—MYC—brain cancer	6.87e-05	0.00048	CbGpPWpGaD
Rivaroxaban—ABCB1—Integrated Pancreatic Cancer Pathway—EGFR—brain cancer	6.72e-05	0.00047	CbGpPWpGaD
Rivaroxaban—CYP3A5—Metabolism—ENO2—brain cancer	6.7e-05	0.000469	CbGpPWpGaD
Rivaroxaban—ABCB1—Metabolism—IDH1—brain cancer	6.4e-05	0.000448	CbGpPWpGaD
Rivaroxaban—ABCB1—Integrated Pancreatic Cancer Pathway—TP53—brain cancer	5.64e-05	0.000395	CbGpPWpGaD
Rivaroxaban—CYP3A4—Metabolism—CYP2C9—brain cancer	5.39e-05	0.000377	CbGpPWpGaD
Rivaroxaban—ABCB1—Metabolism—ENO2—brain cancer	5.06e-05	0.000354	CbGpPWpGaD
Rivaroxaban—CYP3A4—Metabolism—BSG—brain cancer	4.58e-05	0.000321	CbGpPWpGaD
Rivaroxaban—CYP3A4—Metabolism—IDH1—brain cancer	3.94e-05	0.000276	CbGpPWpGaD
Rivaroxaban—CYP3A4—Metabolism—ENO2—brain cancer	3.12e-05	0.000218	CbGpPWpGaD
Rivaroxaban—CYP3A5—Metabolism—PIK3CG—brain cancer	3.08e-05	0.000215	CbGpPWpGaD
Rivaroxaban—ABCB1—Metabolism—PIK3CG—brain cancer	2.32e-05	0.000162	CbGpPWpGaD
Rivaroxaban—CYP3A4—Metabolism—PIK3CG—brain cancer	1.43e-05	0.0001	CbGpPWpGaD
